close

SMS Pharmaceuticals Ltd

Know More
NSEBSE

124.55-1.30 (-1.03%)

03:42 PM,3rd Oct 2023

125.850.00 (0.00%)

04:01 PM,3rd Oct 2023

BSE : 532815

NSE : SMSPHARMA

Sector : Health care

ISIN Code : INE812G01025

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Oct 03 2023 | 04:01 PM IST

Market Cap (₹ Cr)

1054

Turnover (₹ Cr)

0.13

Volume (Shares)

100883

Face Value

1

52-WK High

140.00

52-WK High Date

24 Aug 2023

52-WK Low

54.55

52-WK Low Date

28 Mar 2023

All Time High

198.80

All Time High Date

05 Aug 2021

All Time Low

7.40

All Time Low Date

15 Jan 2009

SMS Pharmaceuticals Ltd

SMS Pharmaceuticals Limited is a Public company incorporated in December 14 1987. The company is engaged in the business of manufacturing of Active Pharma Ingredients and their intermediates. Apart from R &D Center at Gagillapur Hyderabad the company is having manufacturing facilities at Bachupally Hyderabad and also at Kandivalasa in Vijayanagaram Dist. Its business activity is a single primary business segment of 'Bulk Drugs'. During the year 2015 the company has re-enforced its fundamental strength of FDA compliant facilities by successfully completing the US FDA audits at Kandivalasa and Bachupally facilities.During the year 2015 the company filed 9 Drug Master Files and total DMFs filed up to 31 March 2015 are 24.During the year 2014-15 the Company acquired 1225900 equity shares of Rs. 10/- each in M/s. VKT Pharma Private Limited. With this the said company has become an associate company. The project of the said associate company is in final stage and at the verge of completion and operations are yet to be commenced. The Company has not having any subsidiaries.During the year 2015-16 the Company had sub divided the face value of share of Rs 10/- each into face value of Rs 1/- of each with record date of 18th December 2015.During FY 2015-16 the Board has approved the 'Draft Scheme of Arrangement for Demerger of Semi Regulated Units (Unit - I IV & V) along with other Assets to transfer the same to SMS Lifesciences India Limited (Resulting Company) with an object to reduce the impact of Semi Regulated Units on Regulated Units achieving operational efficiencies site synergies and streamlining its current structure. The Draft Scheme of Arrangement is subject to the Approvals of Stock Exchanges Securities Board of India Limited Reserve Bank of India and other regulatory authorities and also Hon'ble High Court of Judicature at Hyderabad for the State of Telangana and Andhra Pradesh.During FY 2016-17 the Company had made investment in it's associate Company viz. M/s. VKT Pharma Private Limited for its business purpose. During the year under review 2016-17 the Company had acquired 511400 equity shares of face value of Rs 10/- each in the said associate at an average price of Rs 157.21. Further the Company had also made an investment in 1000 equity shares of Sireen Drugs Private Limited of Rs 10/- each.SMS Lifesciences India Limited is the wholly owned subsidiary of the Company during the Financial Year 2016-17.In FY 2017-18 the Scheme of arrangement between SMS Pharmaceuticals Limited (Demerged Company) with SMS Lifesciences India Limited (Resulting Company) and their respective Shareholders and Creditors provides for the demerger of the Semi Regulated Units No. I IV and V along with premises situated at Industrial Estate Santhnagar Hyderabad; Industrial Development Area Jeedimetla Hyderabad ; Premises bearing Flat No.417 Nilgiri Aditya Enclave Ameerpet Hyderabad; vacant land admeasuring Ac 19 cents situated at Pharma City Parawada Visakhapatnam and Investments relating to Semi Regulated Units (Demerged Undertaking) of SMS Pharmaceuticals Limited the 'Demerged Company' into SMS Lifesciences India Limited the 'Resulting Company as specified in the scheme. The scheme was approved by the Hon'ble National Company Law Tribunal Hyderabad Bench vide its Order No. C.P (CAA) No.7/230/232/HDB/2017 dated 15th May 2017. The effective date of the Scheme is 17th May 2017. SMS Lifesciences India Limited (Resulting Company) in accordance with the approved Scheme of Arrangement has allotted 3023287 equity shares of Rs.10/- each to the shareholders of the company by fixing Record Date as on 23rd June 2017. Pursuant to approved Scheme the Resulting Company shares will be listed on Stock Exchanges viz. BSE & NSE where the equity shares of SMS Pharmaceuticals Limited are listed.The Company had made investment in its associate company viz. M/s. VKT Pharma Private Limited for its business purpose. During the year under review 2017-18 the Company had acquired 784100 equity shares of face value of Rs.10/- each in the said associate at an average price of Rs.200.81.During FY 2018-19 the Company had made investment in it's associate Company viz. M/s. VKT Pharma Private Limited for its business purpose. The Company held 3850165 equity shares of Rs 10/- each in VKT Pharma Private Limited as on 31st March 2019 as investments.

SMS Pharmaceuticals Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

1054

EPS - TTM (₹) [S]

2.74

P/E Ratio (X) [S]

2.13

Face Value (₹) 1
Latest Dividend (%)30.00
Latest Dividend Date 22 Sep 2023
Dividend Yield (%) 0.24
Book Value Share (₹) [S]58.49
P/B Ratio (₹) [S]2.13
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)
Motilal Oswal S&P BSE Healthcare ETF 0.00 268 0.04

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High

123.60

127.60

Week Low/High

121.10

127.60

Month Low/High

119.50

132.00

Year Low/High

54.55

140.00

All time Low/High

7.21

199.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week2.17%2.17%-0.66-0.69%
1 Month-3.04%-3.15%0.190.48%
3 Month35.38%35.38%0.471.07%
6 Month109.40%109.68%10.8412.25%
1 Year38.39%37.78%15.3615.64%
3 Year38.93%39.01%69.2971.05%

Financials

Graph
Table

Bulk/ Block

ALL
NSE
BSE
ALL
BUY
SELL
DateClient NameExchangeTransactionQuantityPrice
31-12-2020POTLURI INFRA PROJECTS LLPNSEBUY661180115.10
31-12-2020VEERAVENKATA SATYANARAYANA MURTHY TALLURINSESELL661180115.10
08-12-2020ANNAPURNA TALLURINSESELL285858094.70
08-12-2020ANNAPURNA TALLURINSESELL285858094.70
08-12-2020HIMA BINDU POTLURINSEBUY139048094.70
08-12-2020HIMA BINDU POTLURINSEBUY139048094.70
08-12-2020POTLURI INFRA PROJECTS LLPNSEBUY58114095.35
08-12-2020RAMESH BABU POTLURINSEBUY146810094.70
08-12-2020RAMESH BABU POTLURINSEBUY146810094.70
08-12-2020VEERAVENKATA SATYANARAYANA MURTHY TALLURINSESELL58114095.35

Load More

Peer Group Comparison

NamePrice(In Rs)Chg(%)Mkt Cap(Rs Cr)Sales(Rs Cr)Profit(Rs Cr)EPS(Rs)P/E(x)

Shareholding Pattern

Jun 2023
Archive
CategoryShare(%)
Promoter64.32
Financial Institutions Banks0.00
Foreign Institutional Investors0.67
Insurance Companies0.00
Mutual Funds Uti0.00
Other Institutional Investors0.00
Indian Public29.04
Others Non Institutional Investors5.97
Custodians0.00

Corporate Action

Announcement DatePurposeFromToRemarks
Data Not Found

Price History

Search for Price History

DateOpenHighLowCloseSharesTrades
Data Not Found

Load more

Company Info

Company Information

Chairman & Managing Director : P Ramesh Babu

Independent Director : P Sarath Kumar

Independent Director : Thummala Neelaveni

Independent Director : Shravan Kudaravalli

Independent Director : Sarvepalli Srinivas

Executive Director : Vamsi Krishna Potluri

Company Sec. & Compli. Officer : Thirumalesh Tumma

Registered Office: 19 III Rd 71 Opp Bharatividya, Bhavan Public Sch Jubilee Hill,Hyderabad,Telangana-500096 Ph: 91-40-66288888

Email:info@smspharma.com

URL:http://www.smspharma.com